CA
NZ
UK
AU
IND
US
In intraday trading, Intuitive Surgical NASDAQ:ISRG inched marginally higher but remains near multi-year lows as hospital capital constraints, reimbursement scrutiny, and slower-than-expected da Vinci 5 adoption weigh on the stock.Key HighlightsAs of the latest intraday update, Intuitive Surgical gained a fraction to $404.24, trading …
Johnson & Johnson (NYSE:JNJ) is edging higher to $240.07 in Wednesday's session as investors rotate into large-cap healthcare names amid a broader market rebound, with the S&P 500 advancing approximately 0.74% intraday.
Abbott Laboratories (NYSE:ABT) was up 1.29% at $91.70 as of the latest intraday update on Wednesday and was trading in territory not seen in nearly a month, as healthcare and medtech stocks attracted meaningful rotation interest from investors exiting defensive telecom and energy positions.
AbbVie Inc. (NYSE:ABBV) was down 0.43% at $233.75 as of the latest intraday update on Wednesday, as large-cap pharmaceutical names attracted less rotation interest than device and biotech peers during the broader healthcare sector's recovery.
Amgen Inc. (NASDAQ:AMGN) was up 1.48% at $352.15 as of the latest intraday update on Wednesday, as healthcare sector rotation favoured large-cap biotech names with established dividend profiles and late-stage pipeline depth, categories where Amgen holds competitive structural advantages.
As of the latest intraday update, CVS Health (NYSE:CVS) dipped less than 1% to $100.91 on Wednesday, a significantly shallower decline than early estimates suggested, as the pharmacy and health services company continues to trade near its all-time high of $103.12 following a recovery …
As of the latest intraday update, Danaher Corporation (NYSE:DHR) posted the strongest session gain among healthcare names, rising nearly 5% to $187.66, as life-science tools and diagnostics companies rebounded sharply from a prolonged drawdown driven by post-pandemic bioprocessing inventory destocking.
Cerebras Systems posted its initial earnings since going public, delivering results that fell short of market expectations. The company highlighted progress in its AI processor roadmap but did not disclose specific financial metrics. Investors responded with a pronounced sell‑off, indicating skepticism about the firm's …
AI workloads are reshaping semiconductor demand, and Taiwan Semiconductor Manufacturing Co. (NYSE: TSM) has captured a sizable share. High‑performance computing now contributes 61% of the firm’s revenue, underscoring the structural nature of AI orders. This shift is driving both top‑line growth and higher gross …
Veeva Systems has begun to embed advanced artificial intelligence models directly into its cloud infrastructure for life‑science customers. The rollout focuses on generative AI that can assist with regulatory documents, experimental designs, and data interpretation, positioning Veeva as a pioneer among cloud providers serving …
Please wait processing your request...